Flecainide 50, 100, 150 & 200 Cr Forrester 50 mg, 100 mg, 150 mg & 200 mg Capsule
PDF Leaflet Revision Date: August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Control of dysrhythmias including ventricular tachycardia and atrial fibrillation.
Dosage (summary)
Adults: Starting 100 mg/day, max 300 mg/day; high-risk patients: max 100 mg/day.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding; safety not established.
Key Drug Interactions
- Class I antidysrhythmics
- Digoxin
- Amiodarone
- Cimetidine
- Fluoxetine
Contraindications
- Hypersensitivity to flecainide
- Myocardial infarction
- Heart failure
- Complete heart block
Common side effects
- Dizziness
- Visual impairment
- Pro-dysrhythmic effects
- Fatigue
Counselling Points
- Monitor for dizziness and visual disturbances.
- Avoid driving until effects are known.
- Report any new or worsening symptoms.
Serious warnings
- Increased mortality risk in post-myocardial infarction patients
- Caution in patients with conduction disorders
- Pro-dysrhythmic effects
On This Page
Connecting to Document Server
Decrypting and optimizing pharmaceutical leaflet...
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
